Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
122.74
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
122.45 (500)
Ask (Size)
123.44 (100)
Prev. Close
122.74
Today's Range
122.74 - 122.74
52wk Range
88.57 - 128.70
Shares Outstanding
1,253,809,440
Dividend Yield
2.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
↗
Today 10:00 EST
Via
Benzinga
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Performance
YTD
N/A
N/A
1 Month
-1.3%
-1.3%
3 Month
+10.4%
+10.4%
6 Month
+10.1%
+10.1%
1 Year
+32.9%
+32.9%
More News
Read More
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs
↗
December 22, 2025
Via
Stocktwits
What's Driving the Market Sentiment Around Gilead Sciences Inc?
↗
December 31, 2025
Via
Benzinga
Stock Index Futures Slip in Weak End to a Banner Year
December 31, 2025
Via
Barchart.com
Topics
Bonds
Government
Stocks
Discover which S&P500 stocks are making waves on Tuesday.
↗
December 30, 2025
Via
Chartmill
GILEAD SCIENCES INC (NASDAQ:GILD) Shows High Technical and Setup Ratings for a Potential Breakout
↗
December 27, 2025
Via
Chartmill
Jobless Claims Unexpectedly Fall For Second Consecutive Week
↗
December 24, 2025
Via
Stocktwits
Topics
Stocks
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million
↗
December 24, 2025
Via
Benzinga
RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug
↗
December 24, 2025
Via
Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
These S&P500 stocks are moving in today's session
↗
December 23, 2025
Via
Chartmill
Gilead Sciences to Present at Upcoming Investor Conference
December 22, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes
↗
December 22, 2025
Via
Benzinga
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 22, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
↗
December 20, 2025
Via
Benzinga
Topics
Government
Why Gilead Sciences (GILD) Stock Is Up Today
December 19, 2025
Via
StockStory
Topics
Earnings
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
↗
December 19, 2025
Via
Investor's Business Daily
Topics
Government
Stocks
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 19, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Inc. (NASDAQ:GILD): A High-Quality Dividend Stock for Reliable Income
↗
December 19, 2025
Via
Chartmill
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 18, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks
↗
December 17, 2025
Via
Stocktwits
Topics
Government
World Trade
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 122.74
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 12/31/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 153.89B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 154B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.